Federal award
ROCHE DIAGNOSTICS CORPORATION
HT001419F0438
Contract
Obligated and Ceiling
- Obligated (net)
- $5,979,596.00
- Ceiling (potential value, not spending)
- $5,979,596.00
- Current value
- $5,979,596.00
- Gross positive obligations
- $5,979,596.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 97DH · office HT0014
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6630 · CHEMICAL ANALYSIS INSTRUMENTS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT001419F0438
- Parent vehicle (IDV PIID)
- HT001419A0043
- Award type code
- A
- Actions
- 9 · Sep 30, 2019 to Jan 9, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 9, 2024 | FY2024 | P00008 | G | $1,195,919.20 | — |
| Mar 8, 2023 | FY2023 | P00007 | M | $0.00 | — |
| Jan 11, 2023 | FY2023 | P00006 | M | $1,195,919.20 | — |
| Dec 29, 2022 | FY2023 | P00005 | G | $0.00 | — |
| Dec 30, 2021 | FY2022 | P00004 | G | $1,195,919.20 | — |
| Jun 22, 2021 | FY2021 | P00003 | C | $597,959.60 | — |
| Jan 4, 2021 | FY2021 | P00002 | G | $597,959.60 | — |
| Jan 30, 2020 | FY2020 | P00001 | M | $1,195,919.20 | — |
| Sep 30, 2019 | FY2019 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.